Entrada Therapeutics Overview

Entrada Therapeutics Operating Income

Operating Income for TRDA.

Quarterly Operating Income

$-42303000.00

↑ 94.14% YoY

As of Mar 31, 2026

Annual Operating Income (TTM)

$-178411000.00

↓ 4443.01% YoY

Trailing 12 months ending Mar 31, 2026

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin